Transmedics Group Inc (TMDX)

$135.72 +1.73 (1.29%)
Market Cap 4.58B
Revenue (ttm) 441.54M
Net Income (ttm) 35.46M
EPS (ttm) N/A
PE Ratio 56.26
Forward PE 51.31
Profit Margin 8.03%
Debt to Equity Ratio 0.17
Volume 539,200
Avg Vol 760,272
Day's Range N/A - N/A
Shares Out 34.17M
Stochastic %K 27%
Beta 2.03
Analysts Strong Sell
Price Target $144.73

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of s...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 552 0900
Address:
200 Minuteman Road, Suite 302, Andover, United States
Stoop_Kid
Stoop_Kid Feb. 4 at 3:21 AM
$TMDX Good strength today
0 · Reply
EddieGene
EddieGene Feb. 3 at 12:40 PM
$TMDX 🚀🚀🚀
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 2 at 8:04 PM
$TMDX Share Price: $132.84 Contract Selected: Jul 17, 2026 $135 Calls Buy Zone: $20.23 – $24.99 Target Zone: $34.71 – $42.42 Potential Upside: 62% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TriGuy8542
TriGuy8542 Feb. 2 at 4:25 PM
$TMDX I bought 42 more shares.
0 · Reply
Lambster2
Lambster2 Feb. 2 at 3:55 PM
$TMDX TransMedics (NASDAQ: TMDX) Buy Price Target: $170.00 TMDX Organ Transplant Volume and FlightTracker THE TD COWEN INSIGHT We are tracking monthly U.S. heart, liver, and lung transplant volumes and TransMedics Aviation flights. TMDX has moved beyond the early innings of the Organ Care System (OCS) and National OCS Program (NOP) launches, so revenue performances have become levered to US transplant market trends and TransMedics Aviation flight runs.
1 · Reply
TriGuy8542
TriGuy8542 Feb. 2 at 3:12 AM
$TMDX coming into Feb 2 I now think my covered calls will likely expire worthless as the market will punish TMDX like the rest. I intend to buy more share throughout the week. Turning to my three puts sold for March. I suspect they too will expire worthless after a 2026 20% guide and a GREAT recap of 2025 for EOM Feb earnings. Trials, Italy up and running, along with OxMantra device sucking wind will boost lover adoption further. Get ready to ride the market very high on this name as we get the next boom cycle before the eventual oversold moment much later on. This will be a name retail will be all over late this year and I’ll be selling puts only after this month.
0 · Reply
Twister8
Twister8 Jan. 31 at 10:59 PM
$TMDX buy zone again
2 · Reply
NeverPop
NeverPop Jan. 30 at 10:16 PM
$TMDX Baillie Gifford added. Encouraging!
1 · Reply
SuperGreenToday
SuperGreenToday Jan. 30 at 7:08 PM
$TMDX Share Price: $134.76 Contract Selected: Jul 17, 2026 $135 Calls Buy Zone: $19.89 – $24.57 Target Zone: $35.74 – $43.68 Potential Upside: 70% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TriGuy8542
TriGuy8542 Jan. 30 at 3:06 PM
$TMDX Days like this make me realize selling puts and calls on this company is the right move in this market. I’m willing to buy more shares in the low 120’s and play with selling a stack at 141. But why? Because we are going to see a huge resurgence later this year as we rip towards all time highs while the rest of the market gets pummeled! There’s ALWAYS a bull market somewhere
1 · Reply
Latest News on TMDX
TransMedics: Italian NOP Program Reinforces Huge International Opportunity

Feb 3, 2026, 7:15 AM EST - 16 hours ago

TransMedics: Italian NOP Program Reinforces Huge International Opportunity

These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More

Feb 2, 2026, 2:08 PM EST - 1 day ago

These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More

CAR KSS LCID CHH HIMS IBRX MARA

These under-the-radar stocks combine fast growth with big upside potential

Jan 15, 2026, 10:31 AM EST - 19 days ago

These under-the-radar stocks combine fast growth with big upside potential

AGYS ASTH BBT CORT CTRE DCOM DOCN

TransMedics: Strong Growth And A Better Setup

Jan 13, 2026, 12:58 PM EST - 21 days ago

TransMedics: Strong Growth And A Better Setup

TransMedics Group, Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 2:45 AM EST - 21 days ago

TransMedics Group, Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

Jan 12, 2026, 8:10 AM EST - 22 days ago

TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 4:05 PM EST - 5 weeks ago

TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More

Dec 29, 2025, 10:30 AM EST - 5 weeks ago

Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More

HIMS LCID CAR CHH KSS MARA NOG

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Dec 24, 2025, 4:05 PM EST - 5 weeks ago

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

TransMedics Group: I Estimate A Large Upside By The End Of 2028

Dec 24, 2025, 12:27 AM EST - 5 weeks ago

TransMedics Group: I Estimate A Large Upside By The End Of 2028

Looking For A Squeeze? Top 10 Most Shorted Stocks Right Now

Dec 10, 2025, 11:42 AM EST - 7 weeks ago

Looking For A Squeeze? Top 10 Most Shorted Stocks Right Now

CAR CHH HIMS KSS LCID MARA NOG

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 4:05 PM EST - 2 months ago

TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks

Nov 13, 2025, 3:05 PM EST - 2 months ago

Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks

CARS CHH HIMS LCID NOG SPHR SRRK

Polen U.S. Small Cap Growth Q3 2025 Portfolio Performance And Attribution

Nov 6, 2025, 3:50 AM EST - 3 months ago

Polen U.S. Small Cap Growth Q3 2025 Portfolio Performance And Attribution

BE CRS JOBY ODD POWL

TransMedics: Growth Tailwinds Should Provide Upside In 2026

Oct 31, 2025, 11:54 AM EDT - 3 months ago

TransMedics: Growth Tailwinds Should Provide Upside In 2026

TransMedics: Q3 Results Disappointed, As Expected (Rating Upgrade)

Oct 30, 2025, 11:23 AM EDT - 3 months ago

TransMedics: Q3 Results Disappointed, As Expected (Rating Upgrade)

TransMedics Group, Inc. (TMDX) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 10:56 PM EDT - 3 months ago

TransMedics Group, Inc. (TMDX) Q3 2025 Earnings Call Transcript

TransMedics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 4:05 PM EDT - 3 months ago

TransMedics Reports Third Quarter 2025 Financial Results

TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025

Oct 15, 2025, 4:05 PM EDT - 3 months ago

TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025

TransMedics: I'm More Bullish Than Ever

Sep 22, 2025, 9:40 AM EDT - 4 months ago

TransMedics: I'm More Bullish Than Ever

TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy

Sep 22, 2025, 2:00 AM EDT - 4 months ago

TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy

TransMedics: Upcoming Trials Are Critical

Sep 16, 2025, 4:23 PM EDT - 5 months ago

TransMedics: Upcoming Trials Are Critical

TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 12:47 PM EDT - 5 months ago

TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

TransMedics: Just Like The CEO, I'm Buying

Sep 3, 2025, 10:53 AM EDT - 5 months ago

TransMedics: Just Like The CEO, I'm Buying

TransMedics to Present at Upcoming September Investor Conferences

Aug 25, 2025, 4:05 PM EDT - 5 months ago

TransMedics to Present at Upcoming September Investor Conferences

TransMedics: CEO Is Buying Shares Ahead Of A Potentially Concerning Q3

Aug 25, 2025, 3:36 AM EDT - 5 months ago

TransMedics: CEO Is Buying Shares Ahead Of A Potentially Concerning Q3

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

Aug 12, 2025, 8:00 PM EDT - 6 months ago

Technical Tuesday: SPX All-Time High, OKLO Bull Flags & TMDX Bullish SMA

OKLO

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

Aug 4, 2025, 8:00 AM EDT - 6 months ago

TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial

TransMedics: Continued Strength Suggests Further Upside

Aug 1, 2025, 6:25 AM EDT - 6 months ago

TransMedics: Continued Strength Suggests Further Upside

TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 12:28 AM EDT - 6 months ago

TransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call Transcript

TransMedics Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 6 months ago

TransMedics Reports Second Quarter 2025 Financial Results

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 4:05 PM EDT - 6 months ago

TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

Why TransMedics Remains A Buy Into 2026

Jul 25, 2025, 11:57 AM EDT - 6 months ago

Why TransMedics Remains A Buy Into 2026

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

Jul 23, 2025, 4:17 PM EDT - 6 months ago

This Company Transports Donated Organs. Its Stock Has Had a Roller-Coaster Ride.

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Jul 16, 2025, 4:05 PM EDT - 7 months ago

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

TransMedics: Q2 Analyst Estimates Will Fall Short

Jul 14, 2025, 12:27 AM EDT - 7 months ago

TransMedics: Q2 Analyst Estimates Will Fall Short

TransMedics' Turnaround: The Organ Transplant Leader Is Still A Buy

Jun 23, 2025, 10:00 AM EDT - 8 months ago

TransMedics' Turnaround: The Organ Transplant Leader Is Still A Buy

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect

Jun 17, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out

Jun 15, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation

Jun 12, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation

Jun 10, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 8, 2025, 10:00 AM EDT - 8 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect

Jun 5, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation

Jun 1, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out

May 29, 2025, 10:00 AM EDT - 8 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out

May 27, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect

May 25, 2025, 10:00 AM EDT - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 22, 2025, 10:00 AM EDT - 9 months ago

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

TransMedics: Extremely Undervalued And Extremely Innovative

May 21, 2025, 4:54 AM EDT - 9 months ago

TransMedics: Extremely Undervalued And Extremely Innovative

TransMedics to Present at Upcoming June Investor Conferences

May 20, 2025, 4:05 PM EDT - 9 months ago

TransMedics to Present at Upcoming June Investor Conferences

Stoop_Kid
Stoop_Kid Feb. 4 at 3:21 AM
$TMDX Good strength today
0 · Reply
EddieGene
EddieGene Feb. 3 at 12:40 PM
$TMDX 🚀🚀🚀
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 2 at 8:04 PM
$TMDX Share Price: $132.84 Contract Selected: Jul 17, 2026 $135 Calls Buy Zone: $20.23 – $24.99 Target Zone: $34.71 – $42.42 Potential Upside: 62% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TriGuy8542
TriGuy8542 Feb. 2 at 4:25 PM
$TMDX I bought 42 more shares.
0 · Reply
Lambster2
Lambster2 Feb. 2 at 3:55 PM
$TMDX TransMedics (NASDAQ: TMDX) Buy Price Target: $170.00 TMDX Organ Transplant Volume and FlightTracker THE TD COWEN INSIGHT We are tracking monthly U.S. heart, liver, and lung transplant volumes and TransMedics Aviation flights. TMDX has moved beyond the early innings of the Organ Care System (OCS) and National OCS Program (NOP) launches, so revenue performances have become levered to US transplant market trends and TransMedics Aviation flight runs.
1 · Reply
TriGuy8542
TriGuy8542 Feb. 2 at 3:12 AM
$TMDX coming into Feb 2 I now think my covered calls will likely expire worthless as the market will punish TMDX like the rest. I intend to buy more share throughout the week. Turning to my three puts sold for March. I suspect they too will expire worthless after a 2026 20% guide and a GREAT recap of 2025 for EOM Feb earnings. Trials, Italy up and running, along with OxMantra device sucking wind will boost lover adoption further. Get ready to ride the market very high on this name as we get the next boom cycle before the eventual oversold moment much later on. This will be a name retail will be all over late this year and I’ll be selling puts only after this month.
0 · Reply
Twister8
Twister8 Jan. 31 at 10:59 PM
$TMDX buy zone again
2 · Reply
NeverPop
NeverPop Jan. 30 at 10:16 PM
$TMDX Baillie Gifford added. Encouraging!
1 · Reply
SuperGreenToday
SuperGreenToday Jan. 30 at 7:08 PM
$TMDX Share Price: $134.76 Contract Selected: Jul 17, 2026 $135 Calls Buy Zone: $19.89 – $24.57 Target Zone: $35.74 – $43.68 Potential Upside: 70% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TriGuy8542
TriGuy8542 Jan. 30 at 3:06 PM
$TMDX Days like this make me realize selling puts and calls on this company is the right move in this market. I’m willing to buy more shares in the low 120’s and play with selling a stack at 141. But why? Because we are going to see a huge resurgence later this year as we rip towards all time highs while the rest of the market gets pummeled! There’s ALWAYS a bull market somewhere
1 · Reply
buylowandwait
buylowandwait Jan. 29 at 8:21 PM
$TMDX This month will have record # of flights, likely end up around 900. Earlier, the highest # of monthly flight was established in April/25 @ 837. The # of flight is growing very nicely, signaling strong 2026 momentum going forward !
1 · Reply
Knot2
Knot2 Jan. 29 at 3:03 AM
CVNA don’t insiders have serious skin in the game? Seems like short reports are just bullying the stock lower, they pick on $TMDX too
0 · Reply
mainman
mainman Jan. 29 at 12:40 AM
$TMDX today’s trading activity was simply described as crazy. I think we are at an inflection point. The stock price was pushed down because on Q3 , Waleed stated on his concall that “ things were good, and the company was focused on its long term goals of achieving new higher amounts of transplants with unheard of success rates”. But the market responded with its typical response “show me the results” and I believe TMDX is at that point . The end of February will provide us longs with the proof and the results. So invest accordingly. The real news though is not to realise the past but to acknowledge the future for Transmedics. In four years time, the stock price I anticipate will be much higher. Good luck everyone ….
0 · Reply
buylowandwait
buylowandwait Jan. 27 at 7:21 PM
$TMDX Flight data continues impress, though slowing down a bit from blazing pace in the beginning of the month. The company is executing nicely in a life saving field, strong hold.
0 · Reply
Vman66
Vman66 Jan. 27 at 2:30 PM
$TMDX
0 · Reply
sellthetop
sellthetop Jan. 26 at 11:29 PM
$TMDX momentum is broken.
2 · Reply
TriGuy8542
TriGuy8542 Jan. 24 at 8:21 PM
$TMDX April’s option chain shows a ton of call interest at 165 strike and above. Let’s see what happens but my original hypothesis has been converted warrants will push this above $200 before we see a sell off. EOY I can see range of 180-210. I have a feeling my Feb 26 call that I sold won’t be exercised if the option chain turns out right. 140 right now looks like the perfect place to collect premium for market makers.
2 · Reply
TriGuy8542
TriGuy8542 Jan. 23 at 9:22 PM
$TMDX all I need is end of day Feb 20 a price less than $141 and I keep my shares AND see nice premium. but should that not happen. I will buy those shares back and hopefully at a marginally higher price
2 · Reply
EddieGene
EddieGene Jan. 23 at 5:23 PM
$TMDX let’s go 🚀🚀🚀
0 · Reply
EddieGene
EddieGene Jan. 23 at 1:52 PM
$TMDX 🚀🚀
0 · Reply
Vman66
Vman66 Jan. 23 at 11:53 AM
$TMDX
0 · Reply
Rstinosk
Rstinosk Jan. 22 at 7:14 PM
$TMDX Started a position here. Will look to add on any weakness.
0 · Reply